1. Home
  2. AUTL vs LYTS Comparison

AUTL vs LYTS Comparison

Compare AUTL & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUTL
  • LYTS
  • Stock Information
  • Founded
  • AUTL 2014
  • LYTS 1976
  • Country
  • AUTL United Kingdom
  • LYTS United States
  • Employees
  • AUTL N/A
  • LYTS N/A
  • Industry
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • LYTS Building Products
  • Sector
  • AUTL Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • AUTL Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • AUTL 590.8M
  • LYTS 551.1M
  • IPO Year
  • AUTL 2018
  • LYTS N/A
  • Fundamental
  • Price
  • AUTL $2.37
  • LYTS $22.08
  • Analyst Decision
  • AUTL Strong Buy
  • LYTS Strong Buy
  • Analyst Count
  • AUTL 3
  • LYTS 2
  • Target Price
  • AUTL $10.20
  • LYTS $28.00
  • AVG Volume (30 Days)
  • AUTL 1.2M
  • LYTS 179.3K
  • Earning Date
  • AUTL 03-13-2025
  • LYTS 01-23-2025
  • Dividend Yield
  • AUTL N/A
  • LYTS 0.91%
  • EPS Growth
  • AUTL N/A
  • LYTS N/A
  • EPS
  • AUTL N/A
  • LYTS 0.76
  • Revenue
  • AUTL $10,091,000.00
  • LYTS $523,020,999.00
  • Revenue This Year
  • AUTL $851.83
  • LYTS $17.21
  • Revenue Next Year
  • AUTL $264.18
  • LYTS $9.55
  • P/E Ratio
  • AUTL N/A
  • LYTS $29.02
  • Revenue Growth
  • AUTL 82.71
  • LYTS 10.45
  • 52 Week Low
  • AUTL $2.07
  • LYTS $13.35
  • 52 Week High
  • AUTL $7.37
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • AUTL 46.88
  • LYTS 61.15
  • Support Level
  • AUTL $2.12
  • LYTS $19.07
  • Resistance Level
  • AUTL $2.38
  • LYTS $25.50
  • Average True Range (ATR)
  • AUTL 0.13
  • LYTS 0.92
  • MACD
  • AUTL 0.02
  • LYTS 0.42
  • Stochastic Oscillator
  • AUTL 37.23
  • LYTS 54.82

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.

Share on Social Networks: